Business · 10/06/1999Updated: 10/17/2026 · 1 min read
Merck & Co., Inc., et al.; Withdrawal of FDA Approval for 32 New Drug Applications and 48 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) is withdrawing approval for 32 new drug applications and 48 abbreviated new drug applications, following notifications from the applications' holders that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →